4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide
C119H164F2N26O16S6 — CID 162051107
Data last refreshed: (MolForge compound catalog, from PubChem)
IUPAC4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide
SMILESCC[C@@H](CO)NC(=O)c1nc(C(=O)N2CCC[C@@H]2C)c(-c2cnc(NC(C)C)cc2C)s1.CC[C@H](CO)NC(=O)c1nc(C(=O)N2CCC[C@@H]2C)c(-c2cnc(NC(C)C)cc2C)s1.C[C@H]1CCCN1C(=O)c1nc(C(=O)NC2CCOCC2)sc1-c1cnc(NC(C)(C)C)cc1C(F)F.Cc1cc(NC(C)C)ncc1-c1sc(C(=O)NC2CN(S(C)(=O)=O)C2)nc1C(=O)N1CCC[C@@H]1C.Cc1cc(NC(C)C)ncc1-c1sc(C(=O)N[C@H]2CC[C@H](O)C2)nc1C(=O)N1C2CCC1CC2
InChIInChI=1S/C25H33F2N5O3S.C25H33N5O3S.C23H32N6O4S2.2C23H33N5O3S/c1-14-6-5-9-32(14)24(34)19-20(36-23(30-19)22(33)29-15-7-10-35-11-8-15)17-13-28-18(31-25(2,3)4)12-16(17)21(26)27;1-13(2)27-20-10-14(3)19(12-26-20)22-21(25(33)30-16-5-6-17(30)8-7-16)29-24(34-22)23(32)28-15-4-9-18(31)11-15;1-13(2)25-18-9-14(3)17(10-24-18)20-19(23(31)29-8-6-7-15(29)4)27-22(34-20)21(30)26-16-11-28(12-16)35(5,32)33;2*1-6-16(12-29)26-21(30)22-27-19(23(31)28-9-7-8-15(28)5)20(32-22)17-11-24-18(10-14(17)4)25-13(2)3/h12-15,21H,5-11H2,1-4H3,(H,28,31)(H,29,33);10,12-13,15-18,31H,4-9,11H2,1-3H3,(H,26,27)(H,28,32);9-10,13,15-16H,6-8,11-12H2,1-5H3,(H,24,25)(H,26,30);2*10-11,13,15-16,29H,6-9,12H2,1-5H3,(H,24,25)(H,26,30)/t14-;15-,16?,17?,18-;15-;15-,16+;15-,16-/m00000/s1
InChIKeyYYOFBNQVSLCSSU-NHYBUOFBSA-N
MW2445.18 g/mol
LogP17.88
Rot. Bonds35
About 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide
4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide (PubChem CID 162051107) has the molecular formula C119H164F2N26O16S6 and a molecular weight of 2445.18 g/mol. Its IUPAC name is 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide.
Molecular Properties
| Compound Name | 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide |
|---|---|
| PubChem CID | 162051107 |
| Molecular Formula | C119H164F2N26O16S6 |
| Molecular Weight | 2445.18 g/mol |
| Exact Mass | 2443.11 |
| IUPAC Name | 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide |
| SMILES | CC[C@@H](CO)NC(=O)c1nc(C(=O)N2CCC[C@@H]2C)c(-c2cnc(NC(C)C)cc2C)s1.CC[C@H](CO)NC(=O)c1nc(C(=O)N2CCC[C@@H]2C)c(-c2cnc(NC(C)C)cc2C)s1.C[C@H]1CCCN1C(=O)c1nc(C(=O)NC2CCOCC2)sc1-c1cnc(NC(C)(C)C)cc1C(F)F.Cc1cc(NC(C)C)ncc1-c1sc(C(=O)NC2CN(S(C)(=O)=O)C2)nc1C(=O)N1CCC[C@@H]1C.Cc1cc(NC(C)C)ncc1-c1sc(C(=O)N[C@H]2CC[C@H](O)C2)nc1C(=O)N1C2CCC1CC2 |
| InChI | InChI=1S/C25H33F2N5O3S.C25H33N5O3S.C23H32N6O4S2.2C23H33N5O3S/c1-14-6-5-9-32(14)24(34)19-20(36-23(30-19)22(33)29-15-7-10-35-11-8-15)17-13-28-18(31-25(2,3)4)12-16(17)21(26)27;1-13(2)27-20-10-14(3)19(12-26-20)22-21(25(33)30-16-5-6-17(30)8-7-16)29-24(34-22)23(32)28-15-4-9-18(31)11-15;1-13(2)25-18-9-14(3)17(10-24-18)20-19(23(31)29-8-6-7-15(29)4)27-22(34-20)21(30)26-16-11-28(12-16)35(5,32)33;2*1-6-16(12-29)26-21(30)22-27-19(23(31)28-9-7-8-15(28)5)20(32-22)17-11-24-18(10-14(17)4)25-13(2)3/h12-15,21H,5-11H2,1-4H3,(H,28,31)(H,29,33);10,12-13,15-18,31H,4-9,11H2,1-3H3,(H,26,27)(H,28,32);9-10,13,15-16H,6-8,11-12H2,1-5H3,(H,24,25)(H,26,30);2*10-11,13,15-16,29H,6-9,12H2,1-5H3,(H,24,25)(H,26,30)/t14-;15-,16?,17?,18-;15-;15-,16+;15-,16-/m00000/s1 |
| InChIKey | YYOFBNQVSLCSSU-NHYBUOFBSA-N |
| XLogP | 17.88 |
| TPSA | 543.40 Ų |
| H-Bond Donors | 13 |
| H-Bond Acceptors | 36 |
| Rotatable Bonds | 35 |
| Heavy Atoms | 169 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2445.18 |
| LogP ≤ 5 | 17.88 |
| H-Bond Donors ≤ 5 | 13 |
| H-Bond Acceptors ≤ 10 | 36 |
Frequently Asked Questions
What is the IUPAC name of 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide?
The IUPAC name of 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide (CID 162051107) is 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide.
What is the SMILES notation for 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide?
The canonical SMILES for 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide is CC[C@@H](CO)NC(=O)c1nc(C(=O)N2CCC[C@@H]2C)c(-c2cnc(NC(C)C)cc2C)s1.CC[C@H](CO)NC(=O)c1nc(C(=O)N2CCC[C@@H]2C)c(-c2cnc(NC(C)C)cc2C)s1.C[C@H]1CCCN1C(=O)c1nc(C(=O)NC2CCOCC2)sc1-c1cnc(NC(C)(C)C)cc1C(F)F.Cc1cc(NC(C)C)ncc1-c1sc(C(=O)NC2CN(S(C)(=O)=O)C2)nc1C(=O)N1CCC[C@@H]1C.Cc1cc(NC(C)C)ncc1-c1sc(C(=O)N[C@H]2CC[C@H](O)C2)nc1C(=O)N1C2CCC1CC2.
What is the InChIKey of 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide?
The InChIKey is YYOFBNQVSLCSSU-NHYBUOFBSA-N. The full InChI is InChI=1S/C25H33F2N5O3S.C25H33N5O3S.C23H32N6O4S2.2C23H33N5O3S/c1-14-6-5-9-32(14)24(34)19-20(36-23(30-19)22(33)29-15-7-10-35-11-8-15)17-13-28-18(31-25(2,3)4)12-16(17)21(26)27;1-13(2)27-20-10-14(3)19(12-26-20)22-21(25(33)30-16-5-6-17(30)8-7-16)29-24(34-22)23(32)28-15-4-9-18(31)11-15;1-13(2)25-18-9-14(3)17(10-24-18)20-19(23(31)29-8-6-7-15(29)4)27-22(34-20)21(30)26-16-11-28(12-16)35(5,32)33;2*1-6-16(12-29)26-21(30)22-27-19(23(31)28-9-7-8-15(28)5)20(32-22)17-11-24-18(10-14(17)4)25-13(2)3/h12-15,21H,5-11H2,1-4H3,(H,28,31)(H,29,33);10,12-13,15-18,31H,4-9,11H2,1-3H3,(H,26,27)(H,28,32);9-10,13,15-16H,6-8,11-12H2,1-5H3,(H,24,25)(H,26,30);2*10-11,13,15-16,29H,6-9,12H2,1-5H3,(H,24,25)(H,26,30)/t14-;15-,16?,17?,18-;15-;15-,16+;15-,16-/m00000/s1.
What are the key properties of 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide?
4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide has a molecular weight of 2445.18 g/mol, XLogP of 17.88, 35 rotatable bonds, 13 hydrogen bond donors, and 36 hydrogen bond acceptors.
Where does this data come from?
All data for 4-(7-azabicyclo[2.2.1]heptane-7-carbonyl)-N-[(1S,3S)-3-hydroxycyclopentyl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-1,3-thiazole-2-carboxamide;5-[6-(tert-butylamino)-4-(difluoromethyl)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(oxan-4-yl)-1,3-thiazole-2-carboxamide;N-[(2S)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;N-[(2R)-1-hydroxybutan-2-yl]-5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-1,3-thiazole-2-carboxamide;5-[4-methyl-6-(propan-2-ylamino)-3-pyridinyl]-4-[(2S)-2-methylpyrrolidine-1-carbonyl]-N-(1-methylsulfonylazetidin-3-yl)-1,3-thiazole-2-carboxamide is sourced from PubChem (CID 162051107), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162051107 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.